Document is current
Any future updates will be listed below
-
Authors
Yee, Elliott J. https://orcid.org/0009-0006-6807-2168
McCarter, Martin D.
Vogel, Jon D.
Schulick, Richard D.
Lieu, Christopher
Lentz, Robert W.
- License Information
-
More Information
Article History
Received: 22 August 2025
Accepted: 29 September 2025
First Online: 3 November 2025
Declarations
:
: There are no relevant conflicts of interest or disclosures except the following: RDS is a coinventor of a patent licensed to DynamiCure (managed by the University of Colorado) outside the submitted work. RWL acknowledges clinical research funding to institution from ALX Oncology, Merck, Lilly, Guardant, EDDC, Boehringer Ingelheim, and AstraZeneca, consulting/advisory role (honoraria to institution) for Agenus, Boehringer Ingelheim, Merck, Natera, and consulting/advisory role (unpaid) for Kahr and EDDC. MDM received clinical research funding to the institution from Merck Inc and Taiho Inc. Consultant for Merck Inc and Iovance Inc. Member of the medical advisory board for Debbie’s Dream Foundation, a non-profit patient advocacy group for gastric cancer.
: The authors declare no competing interests.
